1 The free fraction of azapropazone in the plasma of 37 healthy volunteers ranged from 0.0027 to 0.0070 (0.0044 + 0.0009, mean s.d.). The principal binding protein was found to be albumin. 2 In 27 patients with various degrees of renal failure the free fraction values of azapropazone were markedly enhanced (0.0260 + 0.0239, mean + s.d.) and increased more than tenfold in some patients. There was a weak correlation (r = 0.46, P<0.05) between the free fraction and the clearance of endogenous creatinine. Such correlation was not found for serum creatinine, serum albumin, serum uric acid and serum urea nitrogen. 3 In 32 patients with chronic liver disease the free fraction values of azapropazone were also markedly higher (0.0210 + 0.0242, mean + s.d.) than in healthy subjects. There were statistical significant correlations between the free fraction values and the prothrombin complex activity in the plasma (r = 0.40, P<0.05) and the total bilirubin concentration in the plasma (r = 0.90, P<0.001), respectively. Such correlation was not found for serum albumin, serum glutamic oxalacetic transaminase, serum -y-glutamyl transpeptidase and serum alkaline phosphatase. 4 In patients with kidney and liver disease the free fraction values of azapropazone correlated well with those of the anticoagulant drug phenprocoumon (r = 0.93, P<0
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.